Altropane Websites
Investor Relations-Alseres
Alseres Pharmaceuticals, Inc. (ALSE) is focused on the development of diagnostic and therapeutic products for disorders in the central nervous system (CNS).
Not Applicable
$
8.95
Alseres Pharmaceuticals - Treating Neurodegenerative Disorders & CNS D
Alseres Pharmaceuticals develops diagnostic and therapeutic products such as ALTROPANE, INOSINE, and DAT blockers for neurodegenerative disorders, CNS disorders, movement disorders, and spinal cord injuries.
Not Applicable
$
8.95
